FOURIER LEGACY
Long-term Study of LDL-c Lowering with Evolocumab: Observational Follow-up after the FOURIER OUTCOMES Trial
- Stadium
- klaar
- Middel
- none
- Populatie
- ASCVD
- Fase
- IV
- First Patient In
- 12 maart 2020
- Last Patient In
- 9 februari 2021
- Last Patient Last Visit
- -
National Lead
prof. dr. J. W. Jukema
Cardioloog
Studiedirecteur
